SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
16401852
Source:
http://linkedlifedata.com/resource/pubmed/id/16401852
Search
Subject
(
61
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0002736
,
umls-concept:C0008976
,
umls-concept:C0030899
,
umls-concept:C0034656
pubmed:issue
1
pubmed:dateCreated
2006-1-10
pubmed:abstractText
To assess the efficacy and safety of pentoxifylline, a US Food and Drug Administration-approved drug, in patients with ALS treated with riluzole.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/16401852-16769973
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0401060
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Neuroprotective Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Pentoxifylline
,
http://linkedlifedata.com/resource/pubmed/chemical/Phosphodiesterase Inhibitors
,
http://linkedlifedata.com/resource/pubmed/chemical/Placebos
,
http://linkedlifedata.com/resource/pubmed/chemical/Riluzole
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
1526-632X
pubmed:author
pubmed-author:AsselainBB
,
pubmed-author:GuilletPP
,
pubmed-author:LacomblezLL
,
pubmed-author:LeighP NPN
,
pubmed-author:LudolphAA
,
pubmed-author:MeiningerVV
,
pubmed-author:Pentoxifylline European Group
,
pubmed-author:RobberechtWW
pubmed:issnType
Electronic
pubmed:day
10
pubmed:volume
66
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
88-92
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:16401852-Adolescent
,
pubmed-meshheading:16401852-Adult
,
pubmed-meshheading:16401852-Aged
,
pubmed-meshheading:16401852-Aged, 80 and over
,
pubmed-meshheading:16401852-Amyotrophic Lateral Sclerosis
,
pubmed-meshheading:16401852-Double-Blind Method
,
pubmed-meshheading:16401852-Drug Interactions
,
pubmed-meshheading:16401852-Drug Therapy, Combination
,
pubmed-meshheading:16401852-Female
,
pubmed-meshheading:16401852-Humans
,
pubmed-meshheading:16401852-Male
,
pubmed-meshheading:16401852-Middle Aged
,
pubmed-meshheading:16401852-Muscle Weakness
,
pubmed-meshheading:16401852-Neuroprotective Agents
,
pubmed-meshheading:16401852-Pentoxifylline
,
pubmed-meshheading:16401852-Phosphodiesterase Inhibitors
,
pubmed-meshheading:16401852-Placebos
,
pubmed-meshheading:16401852-Riluzole
,
pubmed-meshheading:16401852-Treatment Failure
pubmed:year
2006
pubmed:articleTitle
Pentoxifylline in ALS: a double-blind, randomized, multicenter, placebo-controlled trial.
pubmed:affiliation
Fédération des Maladies du Système Nerveux, Pavillon Paul Castaigne, AP-HP, Hôpital de la Salpétrière, Paris, France. vincent.meininger@psl.aphp.fr
pubmed:publicationType
Journal Article
,
Randomized Controlled Trial
,
Research Support, Non-U.S. Gov't
,
Multicenter Study